All Stories

  1. Short-term cardiopulmonary efficiency improvement after transcatheter baffle leak closure in a Mustard-operated patient
  2. Cardiac Catheterization for Congenital Heart Disease
  3. Ventricular Septal Defects
  4. Melody Valve Implantation in Pulmonary Position
  5. Recommendations from the Association of European Paediatric Cardiology for training in diagnostic and interventional cardiac catheterisation
  6. Partially uncovered Cheatham platinum-covered stent to treat complex aortic coarctation associated with aortic wall aneurysm
  7. PW082 Mitral Valve Replacement For Surgical Correction of Post Rheumatic Heart Disease In Children In A Tertiary Sub-Saharan Centre
  8. From Bare to Covered
  9. Transcatheter Treatment of Tricuspid Valve
  10. Cardiac magnetic resonance before and after percutaneous pulmonary valve implantation
  11. Role of imaging in interventions on structural heart disease
  12. Residual Shunt after Patent Foramen Ovale Closure: Preliminary Results from Italian Patent Foramen Ovale Survey
  13. Catheter-Based Interventions on Right Ventricular Outflow Tract
  14. Transcatheter PFO closure with GORE® septal occluder: Early and mid‐term clinical results
  15. Residual shunting after percutaneous PFO closure: How to manage and how to close
  16. Historia natural y evolución clínica de los pacientes con síndrome de la cimitarra «no corregido»: un estudio multicéntrico de la Sociedad Italiana de Cardiología Pediátrica
  17. Natural History and Clinical Outcome of “Uncorrected” Scimitar Syndrome Patients: a Multicenter Study of the Italian Society of Pediatric Cardiology
  18. Complications of the CardioSEAL Occluder (NMT Medical)
  19. Transcatheter Closure of Membranous Ventricular Septal Defects—Old Problems and New Solutions
  20. Emergency surgery for extrinsic coronary compression after percutaneous pulmonary valve implantation
  21. Follow up in a developing country of patients with complete atrio-ventricular block : cardiovascular topic
  22. Melody transcatheter pulmonary valve implantation. Results from the registry of the Italian society of pediatric cardiology
  23. Trans-Catheter Treatment in Children and Adults with Congenital Heart Disease
  24. Italian patent foramen ovale survey (I.P.O.S.): Early results
  25. Timing of pulmonary valve replacement after tetralogy of Fallot repair
  26. Over‐the‐wire‐technique device implantation
  27. Telescopic catheter‐in‐long sheath and parallel to a stiff guide wire technique for complex pulmonary artery anatomy
  28. Covered-stent implantation to treat aortic coarctation
  29. Other Transcatheter Procedures
  30. Bi-auricular myxoma associated with atrioventricular dissociation in an 18-year-old boy: a case report
  31. Percutaneous treatment of aortic isthmus atresia
  32. Economy class syndrome complicated by stroke
  33. Protein‐losing enteropathy resolved by percutaneous intervention
  34. Percutaneous versus surgical closure of secundum atrial septal defects: a systematic review and meta-analysis of currently available clinical evidence
  35. Aortic coarctation complicated by wall aneurysm
  36. Fontan conversion with concomitant arrhythmia surgery for the failing atriopulmonary connections: mid-term results from a single centre
  37. Right and Left Ventricular Strain and Strain Rate in Young Adults before and after Percutaneous Atrial Septal Defect Closure
  38. Percutaneous Closure of Patent Foramen Ovale in Patients with Anatomical and Clinical High-Risk Characteristics: Long-Term Efficacy and Safety
  39. Percutaneous closure of multiple defects of the atrial septum: Procedural results and long‐term follow‐up
  40. Adult congenital heart disease
  41. Systematic review and meta‐analysis of currently available clinical evidence on migraine and patent foramen ovale percutaneous closure: Much ado about nothing?
  42. Transcatheter closure of postsurgical residual ventricular septal defects: Early and mid‐term results
  43. Morbidity and Mortality Risk Factors in Adults With Congenital Heart Disease Undergoing Cardiac Reoperations
  44. Implantation of a second Amplatzer device to eliminate residual shunt after transcatheter patent foramen ovale closure
  45. Is steroid therapy enough to reverse complete atrioventricular block after percutaneous perimembranous ventricular septal defect closure?
  46. Is it too early to recommend patent foramen ovale closure for all patients who suffer from migraine? A single-centre study
  47. The impact of treatment of the fetus by maternal therapy on the fetal and postnatal outcomes for fetuses diagnosed with isolated complete atrioventricular block
  48. The natural course and the impact of therapies of cardiac involvement in the mucopolysaccharidoses
  49. Transcatheter closure of congenital ventricular septal defects in adult: Mid-term results and complications
  50. Covered Cheatham-Platinum stents for serial dilatation of severe native aortic coarctation
  51. Prospective evaluation from single centre of pregnancy in women with congenital heart disease
  52. Treatment of isolated secundum atrial septal defects: Impact of age and defect morphology in 1,013 consecutive patients
  53. Surgical treatment of arrhythmias in adults with congenital heart defects
  54. New guidelines from the American Heart Association on prevention of infective endocarditis: a shift in paradigms, albeit raising new questions relative to those with congenitally malformed hearts
  55. Redilation of e-PTFE covered CP stents
  56. Patent foramen ovale percutaneous closure: the no-implant approach
  57. Migraine, stroke and patent foramen ovale: a dangerous trio?
  58. Coronary artery fistulas: How to manage them
  59. Covered stents in patients with complex aortic coarctations
  60. Transcatheter Closure of Perimembranous Ventricular Septal Defects
  61. Contrast-Induced Seizures After Cardiac Catheterization in a 6-Year-Old Child
  62. Percutaneous closure of paravalvular leaks
  63. Percutaneous closure of ventricular septal defects. State of the art
  64. A comparison between the early and mid-term results of surgical as opposed to percutaneous closure of defects in the oval fossa in children aged less than 6 years
  65. The “pull–push” technique to deal with a redundant eustachian valve interfering with placement of a PFO occluder
  66. Inhaled nitric oxide and oral nifedipine in a preterm infant with bronchopulmonary dysplasia and pulmonary hypertension
  67. Congenital aortico-right atrial communication: A rare case in an adult patient
  68. Transcatheter treatment of perimembranous ventricular septal defect, secundum atrial septal defect and patent ductus arteriosus in a child
  69. Combined Atrial Septal Defect Surgical Closure and Irrigated Radiofrequency Ablation in Adult Patients
  70. Percutaneous closure of ventricular septal defects
  71. Is there any difference between surgical outflow reconstruction and transcatheter valvotomy in patients with pulmonary atresia with intact ventricular septum?
  72. Late complete atriovenous block after percutaneous closure of a perimembranous ventricular septal defect
  73. Expanding indications for the treatment of pulmonary artery stenosis in children by using cutting balloon angioplasty
  74. Covered stents in patients with congenital heart defects
  75. The impact of interventional cardiology for the management of adults with congenital heart defects
  76. Percutaneous versus surgical closure of secundum atrial septal defect
  77. Transcatheter Closure of Congenital Ventricular Septal Defect with Amplatzer Septal Occluders
  78. Interventricular Septal Hematoma in Ventricular Septal Defect Patch Closure
  79. What do parents know about the malformations afflicting the hearts of their children?
  80. Endothelialization of ASD devices for transcatheter closure: possibility or reality?
  81. Risk of thrombus formation on devices used to close transcatheter atrial septal defect and patent foramen ovale
  82. CardioSEAL/STARflex versus Amplatzer devices for percutaneous closure of small to moderate (up to 18 mm) atrial septal defects
  83. Patients Operated for Tetralogy of Fallot and with Non-Sustained Ventricular Tachycardia Have Reduced Heart Rate Variability
  84. Percutaneous closure of a coronary fistula between the right coronary artery to the left atrium
  85. Transcatheter closure of atrial septal defect in young children
  86. Transcatheter Closure of Atrial Septal Defect Under Combined Transesophageal and Intracardiac Echocardiography
  87. Transcatheter Closure of an Atrial Septal Defect Within a Giant Aneurysm of the Fossa Ovalis
  88. Heart rate variability in children with hypertrophic cardiomyopathy
  89. Role of Heart Rate Variability in the Early Diagnosis of Diabetic Autonomic Neuropathy in Children
  90. Differential diagnosis between patent foramen ovale and pulmonary arteriovenous fistula in two patients with previous cryptogenic stroke caused by presumed paradoxical embolism
  91. Transcatheter Closure of Residual Atrial Septal Defects After Surgical Closure
  92. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect
  93. Transcatheter treatment of muscular ventricular septal defect and pulmonary valvar stenosis in an infant
  94. The effectiveness of octreotide in the treatment of post-operative chylothorax
  95. Selective coronary angiography in patients younger than 1 year of age
  96. Extended end-to-end anastomosis with modified reverse subclavian flap angioplasty
  97. Transcatheter Closure of Atrial Septal Defects with the STARFlex Device: Early Results and Follow‐Up
  98. Incorporation of HLA-DR into the Envelope of Human Immunodeficiency Virus Type 1 In Vivo: Correlation with Stage of Disease and Presence of Opportunistic Infection
  99. Opitz C trigonocephaly syndrome and midline brain anomalies